Anyone who has been looking into micro cap stocks this year might have noticed that the Enzolytics Inc (OTCMKTS:ENZC) stock has emerged as one of the biggest gainers this year so far.
There was no news about the company on Friday, but the Enzolytics stock was on the move all the same and ended up with gains of 13%. That took its gains for the year so far to as much as 175% and hence, it might be a good time for investors to perhaps start tracking the Enzolytics stock. However, last month the company announced that it devised concrete plans by way of which it seeks to start the clinical trials of its ITV-1 anti-HIV therapy.
Eventually, the company seeks to distribute the therapeutic in the European market. More importantly, Enzolytics also stated at the time that it believes that the ITV-1 anti-HIV therapeutic is also going to help it in bring in significant revenues. It should be noted that earlier on the product had made significant progress towards being awarded a certificate by the Bulgarian Drug Agency. However, the process could not be completed. It now remains to be seen if the Enzolytics stock can continue to add to its gains this coming week.
Market Reaction:
On Friday, ENZC stock surged 13.42% at $0.1927 with more than 35.50 million shares, compared to its average volume of 30.98 million shares. The stock had moved within a range of $0.1650 – 0.2150 after opening the trade at $0.1650. Over the past 52-week, the stock has been trading within a range of $0.0003 – 0.9580.
 stock Turns Volatile: How to Trade Next Week?){kind=link}